FDA.reportPublic FDA data

PANCRELIPASE LIPASE

Substance profile for UNII 8MYC33932O, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
8MYC33932O
Preferred term
PANCRELIPASE LIPASE
Registry number
9001-62-1
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
6406
PubChem
0
NCIt
C84040
INN ID
0
ITIS
180722
NCBI
9823

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm6406https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6406
NCI ThesaurusC84040https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84040
FDA Substance Registration System8MYC33932Ohttps://precision.fda.gov/uniisearch/srs/unii/8MYC33932O

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OThese highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OThese highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP ® (pancrelipase) delayed release capsules Initial U.S. Approval: 20091
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932ODrug Facts2
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20095
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20095
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OThese highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 20092
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OCREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OCREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON (PANCRELIPASE) CAPSULE, DELAYED RELEASE [ABBVIE INC.]57
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.]17
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OZENPEP (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC.]17
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.]14
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCRELIPASE CAPSULE, DELAYED RELEASE [X-GEN PHARMACEUTICALS, INC.]14
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.]12
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPERTZYE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [DIGESTIVE CARE, INC.]12
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.]5
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCREAZE (PANCRELIPASE) CAPSULE, DELAYED RELEASE [JANSSEN PHARMACEUTICALS, INC.]5
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP COVER VANILLA BROAD SPECTRUM SPF50PLUS (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION IOPE AIR CUSHION XP COVER BEIGE BROAD SPECTRUM SPF50PLUS (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]4
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC]4
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OULTRESA (PANCRELIPASE) CAPSULE, DELAYED RELEASE [APTALIS PHARMA US, INC]4
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]3
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]3
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER]3
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OVIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC]3
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OVIOKACE (PANCRELIPASE) TABLET [APTALIS PHARMA US, INC]3
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP NATURAL 31 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]2
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OOPTIMAL HCG DIET PLAN (FUCUS VESICULOSUS, CYANOCOBALAMIN, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, L-CARNITINE, L-ORNITHINE, ANTIMONIUM CRUDUM, THYROIDINUM SUIS,) LIQUID [APOTHECA COMPANY]2
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER]2
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANAKARE PLUS (PANCREATIC ENZYME ) POWDER [NEOGEN CORPORATION-MERCER]2
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCRELIPASE CAPSULE, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]2
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OGUNA-DIGEST (ANGELICA ARCHANGELICA ROOT - ANISUM - ARTEMISIA ABROTANUM FLOWERING TOP - ASCORBIC ACID - CITRULLUS COLOCYNTHIS FRUIT PULP - GENTIANA LUTEA ROOT - MELATONIN - NIACIN - PANCRELIPASE AMYLASE - PANCRELIPASE LIPASE - PORK LIVER - SEROTONIN - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA DIENCEPHALON - SUS SCROFA DUODENUM - SUS SCROFA GALL BLADDER - SUS SCROFA PANCREAS - SUS SCROFA PYLORUS - THIAMINE HYDROCHLORIDE - TRYPSIN - TRYPTOPHAN - ) SOLUTION/ DROPS [GUNA SPA]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OGUNA-DIGEST (ANGELICA ARCHANGELICA ROOT - ANISUM - ARTEMISIA ABROTANUM FLOWERING TOP - ASCORBIC ACID - CITRULLUS COLOCYNTHIS FRUIT PULP - GENTIANA LUTEA ROOT - MELATONIN - NIACIN - PANCRELIPASE AMYLASE - PANCRELIPASE LIPASE - PORK LIVER - SEROTONIN - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA DIENCEPHALON - SUS SCROFA DUODENUM - SUS SCROFA GALL BLADDER - SUS SCROFA PANCREAS - SUS SCROFA PYLORUS - THIAMINE HYDROCHLORIDE - TRYPSIN - TRYPTOPHAN - ) SOLUTION/ DROPS [GUNA SPA]1
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION BLUSHER NO 1 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION IOPE AIR CUSHION BLUSHER NO 2 (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]1
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP COVER LIGHT VANILLA (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]1
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP INTENSE COVER VANILLA (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION IOPE AIR CUSHION XP INTENSE COVER BEIGE (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]1
PANCRELIPASE LIPASEINACTIVE INGREDIENT8MYC33932OIOPE AIR CUSHION XP MATTE LIGHT VANILLA (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION IOPE AIR CUSHION XP MATTE VANILLA (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION IOPE AIR CUSHION XP MATTE BEIGE (OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE) LOTION [AMOREPACIFIC]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH]1
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCREAPOWDER PLUS (PANCREATIC ENZYME CONCENTRATE PLUS FAT SOLUBLE VITAMINS) POWDER [HENRY SCHEIN ANIMAL HEALTH]1
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREPLUS (PANCREATIC ENZYME) TABLET [MWI/VETONE]1
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREVED (PANCREATIC ENZYME) TABLET [VEDCO, INC]1
PANCRELIPASE LIPASEACTIVE INGREDIENT8MYC33932OPANCREZYME POWDER [VIRBAC AH, INC.]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREZYME POWDER [VIRBAC AH, INC.]1
PANCRELIPASE LIPASEACTIVE MOIETY8MYC33932OPANCREZYME TABLET [VIRBAC AH, INC.]1